Business and People September 2014
Industry news focusing on the people and organizations who work in the clinical trials profession.
People
CSSi (Glen Burnie, MD) announced the formation of the company’s Medical and Clinical Advisory Board (MCAB), and the addition of William E. Gannon, Jr., MD, to the MCAB. Gannon serves as Chief Scientific Officer & Medical Director for Capital City Technical Consulting (CCTC) in Washington, DC.
ELC Group (Cambridge, UK) announced the appointment of clinical pharmacologist Siddharth Chachad, MD, as Head of Global Clinical Development and Medical Affairs.
WIRB-Copernicus Group (WCG) (Princeton, NJ) announced that it has appointed David Borasky as Vice President of Quality Management for the Copernicus Group Independent Review Board. Borasky will be responsible for creating and implementing programs, policies and procedures that establish compliance and ethical conduct standards for human research. He will also ensure that the Copernicus Group Independent Review Board complies with all applicable federal and state laws, regulations, and accreditation standards.
Pharmaceutical Product Development, LLC (PPD) (Wilmington, NC) announced the appointment of Robert Hureau as Executive Vice President and Chief Financial Officer. Hureau brings 25 years of experience and extensive financial expertise spanning the medical technology/life sciences, manufacturing and consumer sectors.
ERT (Philadelphia, PA) announced that its President and CEO, Jeffrey S. Litwin, MD has been named Editor-in-Chief of MultiMedia LLC’s new peer-reviewed publication: Journal of Clinical Trial Results. The online, open-access publication serves researchers, clinicians, and other professionals interested in the outcomes of clinical trials.
ICON plc, (Dublin, Ireland) announced the appointment of Ira Spector, PhD, as Executive Vice President, Analytics and Consulting. In this role, Spector will lead ICON’s global consulting and drug development services and will also be responsible for ICON’s business process improvement and analytics capabilities.
Biomedical Systems (Saint Louis, MO) announced the appointment of Richard Kovacs, MD, FACC, FAHA to Chief Cardiologist. As Chief Cardiologist, Dr. Kovacs’ primary objective is to provide sponsors with expert cardiac safety guidance while maintaining the highest regulatory standards.
New Facilities
PRA Health Sciences (Blue Bell, PA) announced the relocation of employees from its Horsham and Fort Washington locations into new modern Class A+ office space in Blue Bell. Once completed, the new facility in Blue Bell will house approximately 860 PRA employees and will include more than 148,000 square feet.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
